Premium
Suppression of Peripheral Pain by Blockade of Voltage‐Gated Calcium 2.2 Channels in Nociceptors Induces RANKL and Impairs Recovery From Inflammatory Arthritis in a Mouse Model
Author(s) -
Baddack Uta,
Frahm Silke,
AntolinFontes Beatriz,
Grobe Jenny,
Lipp Martin,
Müller Gerd,
IbañezTallon Ines
Publication year - 2015
Publication title -
arthritis and rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.106
H-Index - 314
eISSN - 2326-5205
pISSN - 2326-5191
DOI - 10.1002/art.39094
Subject(s) - nociceptor , medicine , blockade , arthritis , inflammation , proinflammatory cytokine , rheumatoid arthritis , pharmacology , nociception , chronic pain , rankl , immunology , activator (genetics) , receptor , psychiatry
Objective A hallmark of rheumatoid arthritis (RA) is the chronic pain that accompanies inflammation and joint deformation. Patients with RA rate pain relief as the highest priority; however, few studies have addressed the efficacy and safety of therapies directed specifically toward pain pathways. The ω‐conotoxin MVIIA (ziconotide) is used in humans to alleviate persistent pain syndromes, because it specifically blocks the voltage‐gated calcium 2.2 (Ca V 2.2) channel, which mediates the release of neurotransmitters and proinflammatory mediators from peripheral nociceptor nerve terminals. The aims of this study were to investigate whether blockade of Ca V 2.2 can suppress arthritis pain, and to examine the progression of induced arthritis during persistent Ca V 2.2 blockade. Methods Transgenic mice expressing a membrane‐tethered form of MVIIA under the control of a nociceptor‐specific gene (MVIIA‐transgenic mice) were used in the experiments. The mice were subjected to unilateral induction of joint inflammation using a combination of antigen and collagen. Results Ca V 2.2 blockade mediated by tethered MVIIA effectively suppressed arthritis‐induced pain; however, in contrast to their wild‐type littermates, which ultimately regained use of their injured joint as inflammation subsided, MVIIA‐transgenic mice showed continued inflammation, with up‐regulation of the osteoclast activator RANKL and concomitant joint and bone destruction. Conclusion Taken together, our results indicate that alleviation of peripheral pain by blockade of Ca V 2.2‐ mediated calcium influx and signaling in nociceptor sensory neurons impairs recovery from induced arthritis and point to the potentially devastating effects of using Ca V 2.2 channel blockers as analgesics during inflammation.